Multiple sclerosis (MS) is a chronic condition affecting the central nervous system. In MS, the immune system attacks the protective myelin coating around nerve fibers, disrupting nerve ...

INDIANAPOLIS (AP) — When Bryce Yoder needs a study break this time of year, the college student flips on a TV and attends his favorite March Madness class — bracket science. The 19-year-old sports ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Our institute offers a diverse range of high-quality intensive English programs designed to meet the needs of students, business professionals, and language enthusiasts from around the world. Whether ...

James Dator has been covering a wide range of sports for SB Nation for over a decade, with a special focus on the NFL. Bill Belichick’s time at North Carolina is already proving quite unique.

The Department of Climate Change and Meteorological Services (MET) says Malawians are still in danger after Cyclone Jude made a landfall in Mozambique yesterday but with minimal impact on Malawi as of ...

Vanuatu, a tiny island nation in the South Pacific, has recently drawn international attention after its Prime Minister, Jotham Napat, ordered the cancellation of fugitive businessman Lalit Modi ...

The detention and attempted deportation of Khalil is a test by Trump to see how far he can go—and a test for us to see how hard we will fight back. Mahmoud Khalil, a student negotiator during ...

The Vanuatu government cancelled the passport issued to Indian Premier League (IPL) founder Lalit Modi, saying that escaping extradition was not a legitimate reason for citizenship in the island ...

Discouraging news from a rival dampened sentiment on the pharmaceutical giant's shares. This concerned a next-generation weight loss drug. That negative investor reaction was directed at companies ...

All right. So, I think we should get started here. For those of you who don't know me, my name is Dave Risinger. I'm responsible for diversified biopharma research at Leerink Partners. It's very ...